February 21, 2017 / 11:45 AM / 9 months ago

BRIEF-Kamada announces collaboration with Massachusetts General Hospital

Feb 21 (Reuters) - Kamada Ltd:

* Kamada Ltd - announced a collaboration with Massachusetts General Hospital

* Kamada Ltd - a collaboration to conduct a proof of concept study evaluating potential benefit of co’s liquid Alpha-1 antitrypsin on liver preservation

* Kamada - purpose of study is to evaluate effect of Kamada’s liquid AAT on graft quality and viability, assess graft for markers of IRI caused to liver Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below